Jenny A.Whalen-Ball


Detroit + 1.313.230.7913

Jenny Whalen-Ball practices primarily in the area of private equity, with a focus on the representation of private equity firms and investment funds. She has experience in acquisitions, debt and equity financings, and other strategic transactions across a number of industries, including health care, manufacturing, technology, and transportation. Jenny's experience also includes counseling closely held corporations on corporate governance and general corporate matters and on intellectual property licensing.

Prior to pursuing a career in law, Jenny served as an editor for an online news organization and worked in higher education communications, where she focused on social media marketing.


  • Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billionJones Day advised Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo") in an acquisition of late stage biopharma companies and formation of alliance with Roivant Sciences Ltd.
  • Nonprofit health system acquires assets of vascular and endovascular physician practiceJones Day advised a nonprofit health system in its acquisition of the assets of a vascular and endovascular physician practice, the integration of those assets into the health system, and employment of the physicians.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • Funds managed by Invesco Asset Management Limited seek advice with demergerJones Day advised funds managed by Invesco Asset Management Limited on U.S. law issues in connection with the demerger of Flarin Holdings Limited and Infirst USA Holdings, LLC from Infirst Healthcare Limited.
  • Concord Health Partners invests in VitalTech™Jones Day represented Concord Health Partners LLC in connection with its purchase of Series A Convertible Preferred Stock in a private placement by VitalTech™, a provider of connected health and remote patient monitoring services.
  • Adtalem Global Education acquires OnCourse Learning's financial services business for $121 millionJones Day advised Adtalem Global Education Inc., a leading workforce solutions provider, in its acquisition of the financial services division of OnCourse Learning, a Brookfield, Wisconsin-based leading provider of compliance training, licensure preparation, continuing education and professional development, for approximately $121 million in cash.
  • Baird Capital acquires minority stake in AEGIS Energy RiskJones Day represented Baird Capital in connection with its minority stake investment in AEGIS Energy Risk, the leading fintech and advisory solutions provider for energy derivatives.
  • Next Generation Films sold to Charter NEX Films, Inc. for $1.07 billionJones Day advised Next Generation Films, Inc. in its sale to Charter NEX Films, Inc., a manufacturer of specialty plastic films, for an aggregate purchase price of $1.07 billion.
  • Baird Capital participates in Series A financing round by ChurnZeroJones Day represented Baird Capital in connection with its purchase of Series A Preferred Stock in a private placement by ChurnZero, a real-time customer success platform.
  • LendingTree acquires ValuePenguin for $105 millionJones Day advised LendingTree, Inc. in its $105 million acquisition of Value Holding Inc., the parent company of, a personal finance website that conducts in-depth research and analysis on a variety of topics from insurance to credit cards.
  • Michigan Health & Hospital Association invests $1 million in NextPlane SolutionsJones Day represented Michigan Health & Hospital Association, a nationally recognized leader on initiatives that protect and promote quality, cost-effective, and accessible healthcare, in connection with its $1 million investment in NextPlane Solutions, LLC, a software company serving the health care industry.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.